Caredx Inc Stock Today
| CDNA Stock | USD 24.91 0.21 0.84% |
Performance0 of 100
| Odds Of DistressLess than 8
|
Caredx is trading at 24.91 as of the 28th of November 2024, a 0.84 percent decrease since the beginning of the trading day. The stock's open price was 25.12. Caredx has only a 8 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Caredx Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 17th of July 2014 | Category Healthcare | Classification Health Care |
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. The company was incorporated in 1998 and is headquartered in South San Francisco, California. CareDx operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 53.63 M outstanding shares of which 3.45 M shares are currently shorted by private and institutional investors with about 3.22 trading days to cover. More on Caredx Inc
Moving together with Caredx Stock
| 0.64 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.82 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Caredx Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Caredx Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Peter Maag | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCaredx can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Caredx's financial leverage. It provides some insight into what part of Caredx's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Caredx Inc (CDNA) is traded on NASDAQ Exchange in USA. It is located in 8000 Marina Boulevard, South San Francisco, CA, United States, 94005 and employs 635 people. Caredx is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.35 B. Caredx Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 53.63 M outstanding shares of which 3.45 M shares are currently shorted by private and institutional investors with about 3.22 trading days to cover.
Caredx Inc currently holds about 306.22 M in cash with (18.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.73.
Check Caredx Probability Of Bankruptcy
Ownership AllocationCaredx holds a total of 53.63 Million outstanding shares. The majority of Caredx Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Caredx Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Caredx. Please pay attention to any change in the institutional holdings of Caredx Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Caredx Ownership Details
Caredx Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| D. E. Shaw & Co Lp | 2024-09-30 | 1.4 M | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.3 M | |
| Renaissance Technologies Corp | 2024-09-30 | 1.2 M | |
| Geode Capital Management, Llc | 2024-09-30 | 1.2 M | |
| Jacobs Levy Equity Management, Inc. | 2024-09-30 | 814.7 K | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 750.9 K | |
| Fmr Inc | 2024-09-30 | 625.5 K | |
| Blue Water Life Science Advisors, Llc | 604 K | ||
| Arnhold & S. Bleichroeder Advisers, Llc | 2024-09-30 | 594.3 K | |
| Blackrock Inc | 2024-06-30 | 5.3 M | |
| Vanguard Group Inc | 2025-03-31 | 4.5 M |
Caredx Historical Income Statement
Caredx Stock Against Markets
Caredx Corporate Management
| GS Jha | Chief VP | Profile | |
| Marco Scheller | Senior Operations | Profile | |
| Ian Cooney | Vice Relations | Profile | |
| Jessica Meng | Chief Officer | Profile | |
| Jeffrey Novack | General Secretary | Profile | |
| Hal Gibson | Senior Planning | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caredx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caredx. If investors know Caredx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caredx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share 5.952 | Quarterly Revenue Growth 0.234 | Return On Assets (0.07) | Return On Equity (0.43) |
The market value of Caredx Inc is measured differently than its book value, which is the value of Caredx that is recorded on the company's balance sheet. Investors also form their own opinion of Caredx's value that differs from its market value or its book value, called intrinsic value, which is Caredx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caredx's market value can be influenced by many factors that don't directly affect Caredx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caredx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caredx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caredx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.